CLRB
$1.12
Cellectar Biosc
$.03
2.75%
CLRB
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.11)
Revenue:  N/A
Monday
Aug 9
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CLRB reports earnings?
Beat
Meet
Miss

Where is CLRB's stock price going from here?
Up
Flat
Down
Stock chart of CLRB
Analysts
Summary of analysts' recommendations for CLRB
Score
Grade
Pivots
Resistance
$1.22
$1.18
$1.15

$1.12

Support
$1.09
$1.05
$1.02
Tweet
Growth
Description
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.